SABRIL

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Estonia, France, Hong Kong SAR China, Ireland, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, South Africa, Tunisia, Turkey, UK.

Active ingredients

The drug SABRIL contains one active pharmaceutical ingredient (API):

1	Vigabatrin UNII GR120KRT6K - VIGABATRIN
	Vigabatrin is a selective irreversible inhibitor of GABA transaminase, the enzyme responsible for the breakdown of GABA (gamma aminobutyric acid). Vigabatrin increases the concentration of GABA, the major inhibitory neurotransmitter in the brain.
	Read more about Vigabatrin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SABRIL Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AG04	Vigabatrin	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2667J, 2668K
BR	Câmara de Regulação do Mercado de Medicamentos	576720070081817
CA	Health Products and Food Branch	02065819, 02068036
EE	Ravimiamet	1116694
FR	Base de données publique des médicaments	61139833, 67326875
GB	Medicines & Healthcare Products Regulatory Agency	21523, 37117
HK	Department of Health Drug Office	35365
IE	Health Products Regulatory Authority	44726, 44768, 44970
JP	医薬品医療機器総合機構	1139013B1026
LT	Valstybinė vaistų kontrolės tarnyba	1080060, 1080061, 1082649
MT	Medicines Authority	MA1359/03101
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	460M93
NL	Z-Index G-Standaard, PRK	31771, 66141
NZ	Medicines and Medical Devices Safety Authority	5938
PL	Rejestru Produktów Leczniczych	100059220, 100097344
SG	Health Sciences Authority	07955P
TN	Direction de la Pharmacie et du Médicament	5933052H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699809090187, 8699809240513
US	FDA, National Drug Code	67386-111, 67386-211
ZA	Health Products Regulatory Authority	28/2.5/0021